Skip to content

Change in Inventories at other companies

Opko Health logo
Opko HealthOPK
-$191K-104%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$185K-9.8%
AMP
Amphastar PharmaceuticalsAMPH
-$6.25M-120%
HRO
HarrowHROW
$2.97M+21,136%
Precigen logo
PrecigenPGEN
$4.88M
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$2.17M+8.9%

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$824.68M+13.4%
Enterprise value$810.08M+12.7%
P/S-4.9×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s change in inventories?
Phathom Pharmaceuticals, Inc. (PHAT) reported change in inventories of -$665K in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
Phathom Pharmaceuticals, Inc.'s change in inventories decreased by 105.4% year-over-year, from $12.33M to -$665K.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.